Congestive heart failure as an indication for continuous renal mmol/liter), potassium 5.9 mmol/liter (3.5 to 5.0 mmol/ replacement therapy. Continuous venovenous hemofiltration liter), and blood urea nitrogen 55 mg/dl (Ͻ28 mg/dl).
liter), and blood urea nitrogen 55 mg/dl (Ͻ28 mg/dl).
(CVVH) is the most widely used renal replacement therapy
The mean arterial pressure was 80 mm Hg, heart rate for the treatment of critically ill patients with acute renal failure was 90 beats per minute, and the central venous pressure on the intensive care unit. Whether or not congestive heart was 24 mm Hg. Initial treatment with catecholamines failure is an indication for CVVH is controversial and needs to be discussed. Therefore, we present a patient with congestive and high doses of furosemide (1000 mg in 6 hr) in order heart failure who was treated successfully with CVVH.
to stimulate renal fluid excretion was unsuccessful; therefore, the patient was treated with continuous venovenous hemofiltration (CVVH) for 10 hours (Fig. 1) . A lactateWhile continuous venovenous hemofiltration (CVVH) buffered solution (45 mmol/liter) was applied at a filtrais the most often used renal replacement therapy for tion rate of 1000 ml/hr and a substitution rate of 750 ml/hr, critically ill patients with acute renal failure, its use for resulting in a negative fluid balance of 250 ml/hr. In order those with severe congestive heart failure remains a topic to reduce the preload, a maximal ultrafiltration volume for discussion. After the initial cardiogenic shock, acute of 2,500 ml was reached. Immediately after the beginning renal failure and impaired renal perfusion often occur, of CVVH therapy, the patient's diuresis returned. The and if renal function is not swiftly restored then multiamount of catecholamines administered was reduced sigorgan damage and death can result. These decompennificantly, and symptoms of CHF such as dyspnea and sated patients are usually resistant to diuretics and have edema improved. The central venous pressure (CVP) a massive fluid overload; their prognosis is poor. This fell to a minimum of 19 mm Hg. The mean arterial article examines one case in light of the current literature, pressure increased to 120 mm Hg, and the heart rate was and discusses therapeutic options for the management unchanged. The patient developed a sufficient diuresis of congestive heart failure patients who are in critical care.
under further diuretic therapy, and renal function reWe report the case of a 40-year-old male who was turned to normal (creatinine 1.1 mg/dl) after four days. admitted to the intensive care unit because of severe
The hemodynamic situation of the patient under a therapy congestive heart failure (CHF). The patient suffered with dobutamine in a low dose intravenous (15 mg/hr) from dilative cardiomyopathy as a consequence of viral and angiotensin-1 receptor blocker (Lorzaar dilative cardiomyopathy, the patient underwent a sucThe relevant laboratory values were as follows: aspartate cessful heart transplantation two months later. aminotransferase (AST) 410 U/liter (Ͻ17 U/liter), alaThis case report presents a patient with acute decomnine aminotransferase (ALT) 260 U/liter (Ͻ23 U/liter), pensation of CHF by cardiomyopathy. The patient had bilirubin 5.4 mg/dl (Ͻ1.1 mg/dl), alkaline phosphatase acute renal failure in the beginning of onset, and suffered (ALP) 244 U/liter (Ͻ180 U/liter), serum creatinine 2. 7 from liver congestion and pulmonary edema. He needed mg/dl (1.2 mg/dl), sodium 135 mmol/liter (135 to 145 catecholamines to stabilize the hemodynamic situation, but did not respond to large doses of diuretics. Early use of CVVH led to an increase in urinary output, raised as well as renal function. CVVH therapy led to a stabilistate with peripheral edema, pleural effusion, and edema of the lung, and they do not respond to diuretic therapy. zation of the patient and prevented further deterioration Thus, they are in a state of decompensated heart failure of organ function.
with a high sodium and water retention as a neurohumoral response to low cardiac output. When these pa-CONTINUOUS VENOVENOUS tients show no improvement under therapy with cate-HEMOFILTRATION IN SEVERE CONGESTIVE cholamines in high doses and a maximum of diuretic HEART FAILURE therapy, hemofiltration might be beneficial. In cardiogenic shock after massive myocardial inThe use of hemofiltration as an intermittent [4] [5] [6] [7] or farction or low-output syndrome caused by cardiomyopa continuous [8] [9] [10] therapy in patients with severe CHF athy, acute renal failure and loss of diuresis caused by has been described by several authors. In a study of renal perfusion impairment is frequent. This leads to arteriovenous hemofiltration, Kramer et al included pafluid and electrolyte imbalance and the accumulation of tients with CHF and overhydration who were resistant toxic metabolites, which also further suppresses cardiac to diuretic therapy [11] . Next to arteriovenous hemofilfunction. These factors contribute to marked cardiovastration [6, 11] , the venovenous approach is the most cular instability. In these patients, the performance of widely used technique [6, 8, 9] . Most studies are patient intermittent hemodialysis is not recommended because surveys [5, 6, 12] or case reports [10] . Only a few studies of severely compromised hemodynamics. Therefore, exist in which patients were systematically investigated CVVH is administered in order to remove excess body [8, [13] [14] [15] [16] . Patients with CHF were treated for a short fluid, to correct metabolic acidosis, and to eliminate ureperiod of time [4, 8, 9, 13, 14] or for a long period up to mic metabolites. As a result, an improvement of the several months [6, 7, 12] . The effects of hemofiltration in cardiovascular situation is observed. Therefore, CVVH CHF included: a relief of the patients' symptoms [4, 6, 9], in patients with cardiogenic shock and acute renal failure a decrease of central venous or right atrial pressure is the first choice for renal replacement therapy [1] .
[4, 5, 9] , and a lowered capillary wedge pressure [4, 5, 9], Whether or not CVVH is indicated even in an earlier which led to an increase of urinary output [4, 13, 16] . state of cardiac dysfunction, when renal failure is imUse of hemofiltration for a long period of time led to pending and multiorgan dysfunction caused by low carweight reduction, a reduced hospital stay, or reduced diac output might be prevented, is of specific interest. diuretic treatment [12] . All of these studies showed the Congestive heart failure is characterized by low carlong-lasting effect of the hemofiltration and that the padiac output and leads to sodium and water retention tients were able to respond to pharmacological therapy [2], neuroendocrine activation, and constriction of the again. peripheral circulation. Therapeutic options include pharIn patients with moderate heart failure, it was shown macological therapies, the use of mechanical devices, that a single session of ultrafiltration led to an improveand heart transplantation [3]. The type of treatment apment of hemodynamics, including a significant increase plied to a patient depends on the symptoms, the cause of the cardiac index [14] . Furthermore, compared to an for heart failure, and the time of progression. There are infusion of furosemide, the markers reflecting neurohumoral activity returned to normal by ultrafiltration. The some patients who appear to be in a decompensated
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removal of 1.6 liters by ultrafiltration compared to a sustained break of the vicious cycle of neurohumoral activity and water and sodium retention are achieved. removal of 1.6 liters by diuretics led to a sustained decrease in of the levels of norepinephrine, renin, and aldoIn some of the studies cited, the patients had no renal failure, which means they had oliguria but no anuria sterone [15] . One single intermittent hemofiltration therapy with the filtration of 2983 Ϯ 1228 ml increased with a creatinine of less than 2.0 mg/dl. The point is that renal failure is more a question of definition and time. urinary output and sodium excretion and led to a fall in norepinephrine levels, effects that persisted for 24 to 48
In reality, in most patients, prerenal azotemia is present or acute renal failure is impending because of low cardiac hours [13] . Thus, these studies showed surprisingly that the effect of hemofiltration was superior to the effect of output and decreased renal plasma flow. However, according to current literature, it seems that an early start diuretic therapy [13] [14] [15] [16] .
The outcome of patients with heart failure grade IV of water and sodium removal by hemofiltration is best [8, 9] . As in the presented case, an early start of hemofilaccording to the New York Health Association (NYHA) was poor in most of the studies, but the parameters tration prevents further multi-organ deterioration, stabilizes cardiac function, improves renal function, and, in related to poor prognosis before starting CVVH therapy were oliguria for more than 15 hours or a creatinine of some cases, it might prevent the intubation and mechanical ventilation of the patient. Thus, hemofiltration in more than 4.0 mg/dl [9] . The patient with the best outcome had the shortest time of oligo-anuria and had the CHF is indicated by fluid overload resistant to diuretics alone and not as usual by azotemia, high potassium levgreatest benefit from the therapy [9] . CVVH started preoperatively in patients with severe heart failure and unels, or acid-balance disorders. It is not yet clearly understood whether the beneficial effect of CVVH in CHF is dergoing cardiopulmonary bypass surgery resulted in an improvement of all hemodynamic variables during hea single effect of preload reduction or the effect of the reduction of toxic metabolites [8] , like a myocardial demofiltration and the restoration of renal function [8] . This suggests that an early start of CVVH in CHF is pressant factor [18] . Although many CHF patients have been treated with HF, there are no controlled studies necessary to improve the patient's chance for survival.
on this topic. While our reported patient showed an The results of these studies show that CVVH treatimprovement with this therapy, the overall prognosis of ment is a useful tool to interrupt further fluid retention these patients remains poor. and to re-establish a sufficient renal function. Responsiveness to diuretic therapy is restored and diuresis returns. CVVH is especially useful in patients with severely CONCLUSIONS compromised cardiac function and the beginning of renal Hemofiltration is a therapeutic option for the managefunction impairment. It leads to an immediate reduction ment of cardiac failure and is ideal to bridge the time in preload, and therefore, renal perfusion is restored.
to transplantation. In some cases, hemofiltration may CVVH may also be employed in patients with severely help to prolong the lifespan of patients with CHF. The compromised cardiac function who are awaiting a heart important fact is that renal replacement therapy has to transplantation in order to carefully reduce excess body be started early to prevent further organ damage and to fluid and stabilize the patient before the heart surgery. prevent further multi-organ dysfunction. For this reason, CVVH was included in the guidelines Future studies should focus the question of whether of therapeutic options for the treatment in severe heart the prognosis of patients with CHF can be improved under failure by the Task Force of the Working Group on Heart application of continuous renal replacement therapies. In severe CHF, hemofiltration is a helpful tool to treat REFERENCES the decompensated patient, who is resistant to diuretics and suffers from massive fluid overload. In the acute ter removal, but here peritoneal dialysis has been suc-3. Remme WJ, for the Task Force of the Working Group on Heart cessfully applied [17] . The beneficial effects of hemofil- of symptoms, a new response to diuretic therapy, and a
